Drug pricing

US sets deadline for Novartis and other pharma firms to lower prices

This content was published on Aug 1, 2025 US President Donald Trump says he has sent letters to Swiss giant Novartis and other pharma firms calling for lower drug prices in the United States – or face retaliation.

Roche CEO: 'Agreement between Bern and Washington within days, if not hours'

Drug pricing

Switzerland very close to tariff deal with the US, says Roche CEO

This content was published on Jul 25, 2025 An understanding between Berne and Washington in the dispute over customs barriers is close: Roche CEO Thomas Schinecker is convinced of this.

Drug pricing

Roche boss says ‘very easy’ to cut US drug prices by 50%

This content was published on Jul 24, 2025 Swiss pharma group Roche is in talks with Washington to bypass middlemen and sell directly to consumers.

A machine dispenses pharmaceutical capsules into blister packs.

Drug pricing

Potential US tariff exemption for Swiss pharma is not necessarily a boon

This content was published on Jul 22, 2025 Donald Trump is pressuring the pharma industry with tariffs. But experts say that tariffs will have less impact on the industry than pricing.

Medicine access

Sandoz board chair ‘convinced that common sense will ultimately prevail’ on US pharma tariffs

This content was published on Jun 28, 2025 In an exclusive interview with Swissinfo, Sandoz chair Gilbert Ghostine says he remains optimistic despite looming tariff hikes.

A young patient is fitted with an exoskeleton.

Medicine access

Rare diseases take centre stage at global health summit

This content was published on May 27, 2025 Rare diseases have been recognised as a global health priority for the first time. How could this impact access to life-saving treatment?

Medicine access

Despite Trump’s bold claims, medicine prices in Europe won’t rise anytime soon

This content was published on May 15, 2025 US President Trump has taken aim at Europe for undercharging for medicine. But raising prices in Europe would face strong pushback.

Medicine access

Trump’s promise to lower drug prices rattles Swiss pharma stocks

This content was published on May 12, 2025 US President Trump wants to make medicines cheaper in the US, which could mean huge losses for drugmakers, including those in Switzerland.

There are thousands of videos about weight-loss drugs on social media that can be seen from anywhere in the world.

Medicine access

Swiss regulator and media clash over weight-loss drugs

This content was published on Jan 21, 2025 Swissmedic has taken legal action against media for alleged unauthorised advertising of weight-loss drugs. Swiss media say this is censorship.

Medicine access

Whatever happened to the world’s most expensive drug?

This content was published on Apr 23, 2024 Swiss pharma giant Novartis launched Zolgensma five years ago with a price tag of $2.1 million. What happened to it?

Drug pricing

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Drug pricing

More

US sets deadline for Novartis and other pharma firms to lower prices

More

Switzerland very close to tariff deal with the US, says Roche CEO

More

Roche boss says ‘very easy’ to cut US drug prices by 50%

More

Potential US tariff exemption for Swiss pharma is not necessarily a boon

More

Sandoz board chair ‘convinced that common sense will ultimately prevail’ on US pharma tariffs

More

Rare diseases take centre stage at global health summit

More

Despite Trump’s bold claims, medicine prices in Europe won’t rise anytime soon

More

Trump’s promise to lower drug prices rattles Swiss pharma stocks

More

Swiss regulator and media clash over weight-loss drugs

More

Whatever happened to the world’s most expensive drug?

Popular Stories

Most Discussed